beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Blood

• Publication date

  1985-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1182/BLOOD.V66.5.1086.BLOODJOURNAL6651086PMID 4052628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles.

  1984cited by this paper
• Complete amino acid sequence of human plasma beta 2-glycoprotein I.

  1984cited by this paper
• Direct assay of factor XIIa in plasma with synthetic chromogenic substrates.

  1983cited by this paper
• Characterization of subfractions of beta 2-glycoprotein I: evidence for sialic acid microheterogeneity.

  1983cited by this paper
• Characterization of the interaction between beta 2-glycoprotein I and mitochondria, platelets, liposomes and bile acids.

  1983cited by this paper
• Amplification of Immunoprecipitates in Agarose Gels by Horseradish Peroxidase‐labelled Antibody

  1983cited by this paper
• Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease.

  1982cited by this paper
• Addition of deoxycholate in electroimmunoassay and crossed immunofocusing for quantification of beta 2-glycoprotein I and its subfractions.

  1982cited by this paper
• Surface activation of blood coagulation, fibrinolysis and kinin formation

  1980cited by this paper
• Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity.

  1980cited by this paper
• Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.

  1980cited by this paper
• The interaction of heparin with plasma proteins. Demonstration of different binding sites for antithrombin III complexes and antithrombin III.

  1980cited by this paper
• The interaction of heparin with plasma proteins. Demonstration of different binding sites for antithrombin III complexes and antithrombin III.

  1980cited by this paper
• Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.

  1980cited by this paper
• Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions.

  1980cited by this paper
• Molecular assembly in the contact phase of the Hageman factor system.

  1979cited by this paper
• The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions.

  1979cited by this paper
• Binding of beta 2-glycoprotein-I to intralipid: determination of the dissociation constant.

  1979cited by this paper
• Studies on the protein composition of human serum very low density lipoproteins: demonstration of the beta 2-glycoprotein-I.

  1979cited by this paper
• Characterization of an agglutinin from human serum.

  1978cited by this paper
• Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).

  1978cited by this paper
• Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.

  1977cited by this paper
• Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.

  1977cited by this paper
• Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.

  1976cited by this paper
• DNA-binding proteins in Yoshida ascites tumor fluid.

  1976cited by this paper
• Crossed immunoelectrophoresis of human erythrocyte membrane proteins. Immunoprecipitation patterns for fresh and stored samples of membranes extensively solubilized with non-ionic detergents.

  1974cited by this paper
• Inhibition of the adsorption of Hagemen factor (Factor XII) to glass by normal human plasma.

  1974cited by this paper
• 23. Immunization, Isolation of Immunoglobulins, Estimation of Antibody Titre

  1973cited by this paper
• General Remarks on Principles, Equipment, Reagents and Procedures

  1973cited by this paper
• Analysis of bacteriophage T7 early RNAs and proteins on slab gels.

  1973cited by this paper
• Investigations on the genetics and population genetics of the beta 2-glycoprotein I polymorphism.

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Further family studies on the genetic control of beta 2-glycoprotein I concentration in human serum.

  1969cited by this paper
• [On a hereditary beta-2-glycoprotein I deficiency].

  1968cited by this paper
• Inhibition of Hageman factor activation.

  1968cited by this paper
• Separation of subfractions of human beta-2-glycoprotein I.

  1967cited by this paper
• Separation of subfractions of human β2-glycoprotein I

  1967cited by this paper
• The biology and pathology of the initial stages of blood coagulation.

  1966cited by this paper
• ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.

  1964cited by this paper
• Some Observations on the Rôle of Hageman Factor in Blood Coagulation

  1961cited by this paper
• Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.

  1958cited by this paper

• Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications

  2025cites this paper
• Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome

  2025cites this paper
• Investigating the predictive role of serum amyloid A and its association with immunological and coagulation biomarkers in recurrent pregnancy loss

  2025cites this paper
• Complement-coagulation crosstalk in idiopathic membranous nephropathy: The potential pathogenesis and therapeutic perspective.

  2025cites this paper
• Understanding the structure of β2-glycoprotein I: new insights and future paths for antiphospholipid syndrome

  2024cites this paper
• Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context matters.

  2024cites this paper
• Bivariate genome-wide association study of circulating fibrinogen and C-reactive protein levels.

  2024cites this paper
• Genetics of Antiphospholipid Syndrome

  2022cites this paper
• Intracerebral Hemorrhage Genetics

  2022cites this paper
• The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System

  2022cites this paper
• A Comparative Analysis of Anticardiolipin, Anti-Β2-Glycoprotein-1, and Lupus Anticoagulants in Saudi Women with Recurrent Spontaneous Abortions

  2022cites this paper
• The Role of Apolipoproteins in Dengue Infection: A Review

  2021cites this paper
• An allosteric redox switch in domain V of β2-glycoprotein I controls membrane binding and anti-domain I autoantibody recognition

  2021cites this paper
• Potential Use of Serum Proteomics for Monitoring COVID-19 Progression to Complement RT-PCR Detection

  2021cites this paper
• Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications

  2021cites this paper
• Distinct and overlapping effects of β2-glycoprotein I conformational variants in ligand interactions and functional assays.

  2020cites this paper
• Cystathionine β-synthase deficiency: different changes in proteomes of thrombosis-resistant Cbs−/− mice and thrombosis-prone CBS−/− humans

  2020cites this paper
• OMNIPHOBIC LUBRICANT-INFUSED COATINGS FOR BIOSENSORS ENHANCING BIOSENSOR PERFORMANCE WITH OMNIPHOBIC LUBRICANT-INFUSED COATINGS

  2018cites this paper
• Thrombophilia Caused by Beta2-Glycoprotein I Deficiency: In Vitro Study of a Rare Mutation in APOH Gene

  2018cites this paper
• Antı-β2 Glycoprotein I Antibodies in Children with Rheumatologic Disorders

  2017cites this paper
• Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome.

  2017cites this paper
• Porteurs asymptomatiques d'un profil d'anticorps anti-phospholipides à haut risque

  2017cites this paper
• Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome.

  2017cites this paper
• High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.

  2017cites this paper
• β2-glycoprotein I and its antibodies involve in the pathogenesis of the antiphospholipid syndrome.

  2017cites this paper
• Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects.

  2017cites this paper
• Antiphospholipid antibody syndrome : Phenotype assessment

  2017cites this paper
• Comparative Proteomic Analysis of the Effect of the Four-Herb Chinese Medicine ANBP on Promoting Mouse Skin Wound Healing

  2017cites this paper
• High-Flux Dialysis: Clinical, Biochemical, and Proteomic Comparison with Low-Flux Dialysis and On-Line Hemodiafiltration

  2017cites this paper
• Study of molecular mechanisms of myocardial infarction: analysis of deep proteome and redoxome in a pig model of ischemia/reperfusio

  2017cites this paper
• Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.

  2016cites this paper
• Beta 2-Glycoprotein I in Hepatitis B virus infection patients with hepatocellular carcinoma , chronic hepatitis B and acute hepatitis B

  2016cites this paper
• Prevalence of antiphospholipid syndrome in Sudanese women with recurrent miscarriage

  2015cites this paper
• Screening and identification of potential predictive biomarkers for Down’s syndrome from second trimester maternal serum

  2015cites this paper
• Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone*

  2015cites this paper
• The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation

  2015cites this paper
• Circulating anti-β2-glycoprotein I antibodies of peripheral arterial disease patients trigger a genomic overexpression of Toll-like receptor 4 in endothelial cells.

  2015cites this paper
• Bouquet variety of antiphospholipid antibodies in recurrent pregnancy loss

  2014cites this paper
• Identification of APOH polymorphisms as common genetic risk factors for venous thrombosis in the Chinese population

  2014cites this paper
• Development of a new extraction method for platelet-rich plasma and partial purification of platelet-derived growth factor and transforming growth factor beta

  2014cites this paper
• A potential anti-coagulant role of complement factor H.

  2014cites this paper
• The role of β2-glycoprotein I (β2GPI) carbohydrate chains in the reactivity of anti-β2GPI antibodies from patients with primary antiphospholipid syndrome and in the activation and differentiation of U937 cells.

  2014cites this paper
• Serum lipoprotein(a) complexes with beta2-glycoprotein I levels in patients with ischemic stroke.

  2014cites this paper
• adhesion and aggregation dependent platelet - 2-Glycoprotein I inhibits von Willebrand factor β

  2013cites this paper
• Anti‐β2‐glycoprotein I antibodies

  2013cites this paper
• Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects

  2013cites this paper
• Elevated serum β2-glycoprotein-I-lipoprotein(a) complexes levels are associated with the presence and complications in type 2 diabetes mellitus.

  2013cites this paper
• Genetic determinants of plasma β2‐glycoprotein I levels: a genome‐wide association study in extended pedigrees from Spain

  2013cites this paper
• Domain V Into a Nicked Form 2Glycoprotein I by Cleaving β Plasmin Can Reduce the Function of Human

  2013cites this paper
• Anti – b 2-Glycoprotein I ( b 2 GPI ) Monoclonal Antibodies with Lupus Anticoagulant-like Activity Enhance the b 2 GPI Binding to Phospholipids

  2013cites this paper
• Circulating Anti-Beta2-Glycoprotein I Antibodies Are Associated with Endothelial Dysfunction, Inflammation, and High Nitrite Plasma Levels in Patients with Intermittent Claudication

  2013cites this paper
• El suero de pacientes con enfermedad arterial periférica activa el sistema inmunitario innato a través de los receptores Toll-Like 4 de las células endoteliales

  2013cites this paper
• 2 Lipoprotein ( a ) Oxidation , Autoimmune and Atherosclerosis

  2012cites this paper
• Lipoprotein(a) complexes with beta2-glycoprotein I in patients with coronary artery disease.

  2012cites this paper
• Genetics of intracerebral hemorrhage: Insights from candidate gene approaches.

  2012cites this paper
• Structural Changes in β2-Glycoprotein I and the Antiphospholipid Syndrome

  2012cites this paper
• Detection of anticardiolipin antibody IgG by time-resolved fluoroimmunoassay

  2012cites this paper
• In vitro effect of anti-β₂ glycoprotein I antibodies on P-selectin expression, a marker of platelet activation.

  2012cites this paper
• Role of carbohydrate receptors in the macrophage uptake of dextran-coated iron oxide nanoparticles.

  2012cites this paper
• Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease.

  2012cites this paper
• Lipoprotein(a) Oxidation, Autoimmune and Atherosclerosis

  2012cites this paper
• Beta2-glycoprotein I gene polymorphisms Val247Leu and Trp316Ser in Spanish patients with primary antiphospholipid syndrome

  2012cites this paper
• Genetics of Antiphospholipid Syndrome

  2012cites this paper
• (cid:1) 2 -Glycoprotein I: a novel component of innate immunity

  2011cites this paper
• Proteómica cardiovascular: análisis proteómico de plasma y monocitos circulantes humanos en pacientes con síndrome coronario agudo

  2011cites this paper
• Laboratory Testing for Antiphospholipid Syndrome

  2011cites this paper
• Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease

  2011cites this paper
• Genetics of Antiphospholipid Syndrome

  2011cites this paper
• Effects of ionic strength, temperature and conformation on affinity interactions of β2‐glycoprotein I monitored by capillary electrophoresis

  2011cites this paper
• Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia.

  2011cites this paper
• binding to activated platelets: differences with lupus anticoagulants Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies

  2011cites this paper
• Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems

  2011cites this paper
• Anti-coagulation effect of Fc fragment against anti-β2-GP1 antibodies in mouse models with APS.

  2011cites this paper
• β2‐Glycoprotein I: evolution, structure and function

  2011cites this paper
• (cid:1) 2 -Glycoprotein I: a novel component of innate immunity

  2011cites this paper
• beta(2)-Glycoprotein I: a novel component of innate immunity

  2011cites this paper
• β₂-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator.

  2011cites this paper
• A shotgun proteomic study of the protein corona associated with cholesterol and atheronal-B surface-modified quantum dots.

  2011cites this paper
• β₂-glycoprotein I: a novel component of innate immunity.

  2011cites this paper
• Affinity Capillary Electrophoresis of β 2-glycoprotein I and Anionic Phospholipids Analytical chemistry Diploma work

  2010cites this paper
• Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy

  2010cites this paper
• SERPINE 1 Links Obesity and Diabetes: A Pilot Study.

  2010cites this paper
• Detection of serum beta(2)-GPI-Lp(a) complexes in patients with systemic lupus erythematosus.

  2010cites this paper
• Étude du rôle régulateur de la lamine B1 dans l’activation plaquettaire : base moléculaire de la thromboprotection chez les patients porteurs d'anticoagulant lupique et d'anti-lamine B1

  2009cites this paper
• Apolipoprotein H Promoter Polymorphisms in Relation to Lupus and Lupus-related Phenotypes

  2009cites this paper
• Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients.

  2009cites this paper
• Antiphospholipid antibodies: Paradigm in transition

  2009cites this paper
• Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance.

  2009cites this paper
• Genetic risk factors of thrombosis in the antiphospholipid syndrome

  2009cites this paper
• Specific adsorption of some complement activation proteins to polysulfone dialysis membranes during hemodialysis.

  2009cites this paper
• [A dangerous combination for stroke in young patient: assimilation of the atlas and anti beta2-glycoprotein I antibodies].

  2009cites this paper
• Prospective study on autoantibodies against apolipoprotein H (beta2GPI) in several clinical parameters from patients with terminal renal failure and functioning renal transplants.

  2009cites this paper
• Chapter 5 Tissue Factor in Antiphospholipid Antibody-induced Pregnancy Loss: Thrombosis versus Inflammation

  2009cites this paper
• Eular On-line Course on Rheumatic Diseases - module n°19

  2008cites this paper
• Controversies and unresolved issues in antiphospholipid syndrome pathogenesis and management.

  2008cites this paper
• The antiphospholipid syndrome and heart valve surgery.

  2008cites this paper
• Detection of IgG anti-beta2 glycoprotein-I antibodies in Saudi patients with systemic lupus erythematosis.

  2008cites this paper
• The antiphospholipid syndrome.

  2008cites this paper
• A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss.

  2008cites this paper
• Antiphospholipid Syndrome: Mechanisms Revealed in Erythrocyte and Liposome Studies

  2008cites this paper